108 related articles for article (PubMed ID: 35343853)
21. Determination of the minimal clinically important difference (MCID) of the physician global assessment (PGA) in SLE.
Anderson EW; Mackay M; Franchin G; Aranow C
Ann Rheum Dis; 2022 Aug; 81(9):1336-1337. PubMed ID: 35680388
[No Abstract] [Full Text] [Related]
22. Flexible optical imaging band system for the assessment of arthritis in patients with systemic lupus erythematosus.
Kim Y; Marone A; Tang W; Gartshteyn Y; Kim HK; Askanase AD; Kymissis I; Hielscher AH
Biomed Opt Express; 2021 Mar; 12(3):1651-1665. PubMed ID: 33796379
[TBL] [Abstract][Full Text] [Related]
23. Acute Motor Axonal Neuropathy in Lupus Nephritis.
Bodra D; D'Souza AVL; Khan E
Cureus; 2024 Mar; 16(3):e55603. PubMed ID: 38586696
[TBL] [Abstract][Full Text] [Related]
24. [Current patient care of systematic lupus erythematosus in Rhineland-Palatinate and Saarland].
Alberti C; Dreher M; Triantafyllias K; Schwarting A
Z Rheumatol; 2024 Mar; ():. PubMed ID: 38509358
[TBL] [Abstract][Full Text] [Related]
25. Systemic lupus erythematous as an unusual cause of intussusception in Sudanese woman: A case report.
Salih Mohammadeen SDA; F Eldow Ahmed A; Abdelmutalib Mohamed RE; Osman Hamza SG; Mohammed Elagib E; H Awadalla H; Hassan A; Ahmed AA; Adam Essa ME
Clin Case Rep; 2021 Oct; 9(10):e04939. PubMed ID: 34646563
[TBL] [Abstract][Full Text] [Related]
26. Lupus nephritis prolongs improvement of serositis in systemic lupus erythematosus.
Harada T; Yamashita H; Nakajima S; Kobayashi T; Takahashi H; Kaneko H
Joint Bone Spine; 2024 Apr; 91(4):105727. PubMed ID: 38582364
[No Abstract] [Full Text] [Related]
27. Endobronchial carcinoid presenting as Focal bronchiectasis in a young woman with systemic lupus erythematosus.
Nasir N; Akhlaq S; Shehzad T; Fatimi S
Clin Case Rep; 2021 Oct; 9(10):e04840. PubMed ID: 34745611
[TBL] [Abstract][Full Text] [Related]
28. Macrophage activation syndrome secondary to systemic lupus erythematosus: lesson for the clinical nephrologist.
Sara M; Anna S; Lorenzo B; Valentina B; Giuseppe C
J Nephrol; 2024 Jun; ():. PubMed ID: 38940999
[No Abstract] [Full Text] [Related]
29. Mean Platelet Volume Values May Have not a Predictive Role for the Presence of Nephritis in Systemic Lupus Erythematosus Patients.
Beyan C; Beyan E
Arch Rheumatol; 2017 Dec; 32(4):373-374. PubMed ID: 29900977
[No Abstract] [Full Text] [Related]
30. Advances in Systemic Lupus Erythematosus (SLE): A case for optimism.
Fanouriakis A; Boumpas DT
Mediterr J Rheumatol; 2017 Mar; 28(1):1-3. PubMed ID: 32185247
[No Abstract] [Full Text] [Related]
31. Weaning Maintenance Therapy in Lupus Nephritis: For Whom, When, and How?
Jourde-Chiche N; Bobot M; Burtey S; Chiche L; Daugas E
Kidney Int Rep; 2023 Aug; 8(8):1481-1488. PubMed ID: 37547513
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Type 2 SLE symptoms in patients with a range of lupus nephritis activity.
Rogers JL; Clowse MEB; Pisetsky DS; Criscione-Schreiber LG; Sun K; Sadun RE; Maheswaranathan M; Burshell DR; Doss J; Eudy AM
Clin Rheumatol; 2024 Apr; 43(4):1319-1326. PubMed ID: 38409491
[TBL] [Abstract][Full Text] [Related]
33. Using PROMIS-29 to determine symptom burdens in the context of the Type 1 and 2 systemic lupus erythematosus (SLE) model: a cross sectional study.
Sun K; Eudy AM; Harris N; Pisetsky DS; Criscione-Schreiber LG; Sadun RE; Doss J; Clowse MEB; Rogers JL
J Patient Rep Outcomes; 2023 Dec; 7(1):136. PubMed ID: 38127169
[TBL] [Abstract][Full Text] [Related]
34. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
Castrejón I; Tani C; Jolly M; Huang A; Mosca M
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
[TBL] [Abstract][Full Text] [Related]
35. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.
Holloway L; Humphrey L; Heron L; Pilling C; Kitchen H; Højbjerre L; Strandberg-Larsen M; Hansen BB
Health Qual Life Outcomes; 2014 Jul; 12():116. PubMed ID: 25048687
[TBL] [Abstract][Full Text] [Related]
36. The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity.
Eudy AM; Reeve BB; Coles T; Lin L; Rogers JL; Pisetsky DS; Criscione-Schreiber LG; Doss J; Sadun R; Sun K; Clowse ME
Lupus; 2022 May; 31(6):697-705. PubMed ID: 35343853
[TBL] [Abstract][Full Text] [Related]
37. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.
Rogers JL; Eudy AM; Pisetsky D; Criscione-Schreiber LG; Sun K; Doss J; Clowse MEB
Arthritis Care Res (Hoboken); 2021 Mar; 73(3):386-393. PubMed ID: 31909888
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
